Skip to content
2000
Volume 18, Issue 7
  • ISSN: 1568-0096
  • E-ISSN: 1873-5576

Abstract

One of the crucial reasons of breast cancer therapy failure is an impairment of mechanisms responsible for metabolism and cellular homeostasis, which makes it difficult to foresee the response to the treatment. Targeted therapy in breast cancer is dictated by the expression of specific molecules such as growth factor or hormone receptors. Many types of breast cancer exhibit different abnormalities in the apoptotic pathway, which confer the resistance to many forms of chemotherapy. Because of the fundamental importance of autophagy in the development and progression of cancer and its ability to affect treatment response, there has been an immense research on molecular regulation and signal transduction mechanisms that control this process. Here, we summarize the present knowledge concerning different breast cancer treatment strategies using drugs approved for the treatment of different breast cancer molecular subtypes with targeting pathways and factors associated with autophagy modulation/ regulation.

Loading

Article metrics loading...

/content/journals/ccdt/10.2174/1568009617666171114143330
2018-09-01
2025-05-31
Loading full text...

Full text loading...

/content/journals/ccdt/10.2174/1568009617666171114143330
Loading

  • Article Type:
    Review Article
Keyword(s): Autophagy; breast cancer; HDAC; lysosomes; microtubules; receptors; targeted therapy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test